Register entry
Wuxi Fortune Pharmaceutical Co., Ltd.
Data as of · How to read this entry
- Registered sites
- 1
- Active NDC listings
- 5
- Labeller names
- 2
- Live patents
- 0
- Countries
- 1
- Base
- China
Authorisation
Registered operations
Active ingredient (API) manufacture1Finished drug manufacture1
Sites
Registered establishments
1| Establishment | Address | Registered for | FEI / DUNS |
|---|---|---|---|
| Wuxi Fortune Pharmaceutical Co., Ltd. | No.2 Rongyang 1st Road, Xishan Economic Development Zone, Wuxi, Jiangsu Province 214191, China (CHN) | Active ingredient (API) manufacture, Finished drug manufacture | 3005968356653894501 |
Catalogue
Drug listings by form and route
55 active NDC listings: 4 bulk ingredient, 1 human prescription drug. By marketing category: BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING 3, ANDA 1, BULK INGREDIENT 1.
| Dosage form | NDCs |
|---|---|
| powder | 4 |
| capsule | 1 |
| Route | NDCs |
|---|---|
| oral | 1 |
| Labeller name on the listing | NDCs |
|---|---|
| wuxi fortune pharmaceutical co.,ltd. | 4 |
| wuxi fortune pharmaceutical co., ltd | 1 |
Catalogue
Marketed products
5| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| - | Cantharidin | powder | 65050-0527BULK INGREDIENT |
| - | Mitomycin | powder | 65050-0058BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING |
| Mycophenolate Mofetil | Mycophenolate Mofetil | capsule, oral | 65050-2073ANDA |
| - | Mycophenolate Mofetil | powder | 65050-2101BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING |
| - | Tacrolimus | powder | 65050-0321BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING |
Neighbours
Registered in the same town
3- WuXi Biologics Co., Ltd.Wuxi, CHN · 2 sites
- STA Pharmaceutical US LLCWuxi, CHN
- WU XI ZHONG ZHI WEI NA TECHNOLOGY CO., Ltd.Wuxi, CHN
Compare
Comparable companies in China
- Kingkey MBC Life Technology Group co., LTD.1 site · 158 NDC
- Qingdao Biopeptek Co Ltd1 site · 110 NDC
- Zhejiang Guoyao Jingyue Aerosol Co Ltd1 site · 94 NDC
- Shenzhen iShan Technology Co Ltd1 site · 84 NDC
- Xiamen Kang Zhongyuan Biotechnology Co., Ltd.1 site · 68 NDC
- Changzhou Maokang Medical Products Co., Ltd1 site · 59 NDC
- Jianerkang Medical Co Ltd1 site · 56 NDC
- Zhejiang Ausun Pharmaceutical Co., Ltd.1 site · 55 NDC
- Humanwell PuraCap Pharmaceuticals (Wuhan) Co., Ltd1 site · 40 NDC
- Guangdong Aimu Biological Technology Co Ltd1 site · 39 NDC
Enquiry
Common questions
- Is Wuxi Fortune Pharmaceutical Co., Ltd. FDA approved?
- Wuxi Fortune Pharmaceutical Co., Ltd. holds 1 FDA-registered establishment in China. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
- Where are Wuxi Fortune Pharmaceutical Co., Ltd.'s drugs manufactured?
- The FDA register lists Wuxi. Registered operations: active ingredient (API) manufacture, finished drug manufacture.
- What drugs does Wuxi Fortune Pharmaceutical Co., Ltd. make?
- 5 products are listed under Wuxi Fortune Pharmaceutical Co., Ltd. in the openFDA NDC Directory, most often as powder; capsule. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.